<ion-header>
  <ion-toolbar>
    <ion-title>
      Description
    </ion-title>
    <ion-buttons start>
      <button ion-button (click)="dismiss()">
        <span ion-text color="primary" showWhen="ios">Cancel</span>
        <ion-icon name="md-close" showWhen="android,windows"></ion-icon>
      </button>
    </ion-buttons>
  </ion-toolbar>
</ion-header>


<ion-content padding>
  <ion-row>
    <h4 ion-text color="primary"> Blood Stream Infection</h4>
    <ion-col col-12>
      <ion-card>
        <ion-card-header>
          Type I
        </ion-card-header>
        <ion-card-content>
          <ul>
            <li>
              Ceftriaxone / cefotaxime (For Non - ESBL suspect)
            </li>
            <li text-center>
              or
            </li>
            <li>
              ampicillin / sulbactum
            </li>
          </ul>
        </ion-card-content>
      </ion-card>
      <ion-card>
        <ion-card-header>
          Type II
        </ion-card-header>
        <ion-card-content>
          <ul>
            <li>
              Piperacillin / Tazobactam +/- Amikacin
            </li>
            <li text-center>
              (or)
            </li>
            <li>
              Cefoperazone / Sulbactam +/- Amikacin
            </li>
          </ul>
        </ion-card-content>
      </ion-card>
      <ion-card>
        <ion-card-header>
          Type III
        </ion-card-header>
        <ion-card-content>
          <ul>
            <li>
              Meropenem + Amikacin
            </li>
            <li text-center>
              (or)
            </li>
            <li>
              Imipenem + Amikacin
            </li>
            <li>
              (or) cefepime (last resort reserve group)
            </li>
          </ul>
        </ion-card-content>
      </ion-card>
      <ion-card>
        <ion-card-header>
          Type IV
        </ion-card-header>
        <ion-card-content>
          <ul>
            <li>
              Based on IDSA Guildelines and risk factors empirical antifungal
            </li>
            <li>
              Flucanazole can be added if candida infection is suspected in Febrile Neutropenic patients
            </li>
          </ul>
        </ion-card-content>
      </ion-card>
      <ion-card>
        <ion-card-header>
          NOTE :
        </ion-card-header>
        <ion-card-content ion-text color="light">
          <p text-justify>
            Renal Function to be assessed if INJ.Amikacin is to be continued
          </p>
          <p text-justify>
            Vancomycin or Linezolid if MRSA is suspected
          </p>
          <p text-justify>
            Metronidazole can be added if anaerobic cover of antibiotics is not adequate
          </p>
        </ion-card-content>
      </ion-card>
    </ion-col>
  </ion-row>
</ion-content>